Alfredo Alberti
#125,958
Most Influential Person Now
Researcher
Alfredo Alberti's AcademicInfluence.com Rankings
Alfredo Alberticomputer-science Degrees
Computer Science
#5286
World Rank
#5584
Historical Rank
Computer Engineering
#43
World Rank
#44
Historical Rank
Data Science
#82
World Rank
#84
Historical Rank
Computational Linguistics
#698
World Rank
#710
Historical Rank
Download Badge
Computer Science
Alfredo Alberti's Degrees
- PhD Computer Science Stanford University
- Masters Computer Engineering University of California, Berkeley
- Bachelors Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Alfredo Alberti Influential?
(Suggest an Edit or Addition)Alfredo Alberti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Non-invasive evaluation of liver fibrosis using transient elastography. (2008) (1273)
- A proposed system for the nomenclature of hepatitis C viral genotypes (1994) (1100)
- Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications (2004) (473)
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel (2011) (428)
- Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. (2005) (410)
- Natural history and prognostic factors for chronic hepatitis type B. (1991) (402)
- Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV (1992) (402)
- Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. (1982) (356)
- Management of hepatitis C. (2003) (340)
- Global burden of disease (GBD) for hepatitis C (2004) (291)
- Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti‐HBe in chronic hepatitis type B (1986) (291)
- Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. (2006) (279)
- Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. (1993) (273)
- Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. (2006) (270)
- Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study (1994) (255)
- Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. (1980) (248)
- Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. (2010) (242)
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. (1997) (241)
- Clinical and virological profiles in patients with multiple hepatitis virus infections. (1993) (239)
- Effect of peginterferon alfa‐2a on liver histology in chronic hepatitis C: A meta‐analysis of individual patient data (2004) (234)
- Natural history of hepatitis C. (2000) (216)
- SAFE biopsy: A validated method for large‐scale staging of liver fibrosis in chronic hepatitis C (2009) (213)
- Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes (1990) (211)
- Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. (2006) (200)
- Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. (1994) (192)
- Randomized trial comparing three different regimens of alpha‐2a‐interferon in chronic hepatitis C (1995) (190)
- Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis. (1982) (183)
- Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. (1987) (179)
- High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. (1992) (178)
- Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection (2002) (168)
- Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. (1989) (167)
- A randomized controlled trial of lymphoblastoid interferon‐α in patients with chronic hepatitis B lacking HBeAg (1992) (163)
- Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV‐RNA levels (2000) (152)
- Hepatitis C virus infection in chronic hepatitis B virus carriers. (1991) (145)
- Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. (2007) (145)
- Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus‐related cirrhosis (1997) (145)
- Hepatitis C serotype and response to interferon therapy. (1994) (140)
- The global health burden of hepatitis C virus infection (2011) (140)
- Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. (1980) (139)
- The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C. (1995) (137)
- Long‐term follow‐up of anti‐HBe‐positive chronic active hepatitis B (1988) (136)
- Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis (1998) (133)
- HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. (1989) (132)
- The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. (1995) (132)
- Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study. (2010) (129)
- The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non‐invasive fibrosis biomarkers: an international study of 2411 cases (2011) (128)
- Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. (1995) (123)
- Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study. (2018) (123)
- Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative study (2002) (122)
- Therapy of acute hepatitis C (2002) (119)
- Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. (2001) (109)
- Therapy of hepatitis C: Re‐treatment with alpha interferon (1997) (106)
- Antibody to hepatitis C virus in post-transfusion hepatitis. (1991) (105)
- A seven‐gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C (2009) (104)
- Persistent Hepatitis C Viremia Predicts Late Relapse after Sustained Response to Interferon- in Chronic Hepatitis C (1996) (99)
- LIVER DISEASE IN ANTI-HBe POSITIVE CHRONIC HBsAg CARRIERS AND HEPATITIS C VIRUS (1989) (94)
- Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features (1998) (93)
- Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature (2000) (92)
- T lymphocyte sensitization to hbcag and T cell‐mediated unresponsiveness to HBsAg in hepatitis B virus‐related chronic liver disease (1985) (89)
- Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development (2001) (89)
- Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. (1996) (88)
- Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group (2004) (88)
- Review article: chronic hepatitis C – natural history and cofactors (2005) (87)
- The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group. (1999) (85)
- Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy. (1996) (84)
- Recombinant interferon‐alfa therapy in children with chronic hepatitis C (1995) (79)
- Fibrosis progression in initially mild chronic hepatitis C (2006) (79)
- Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. (1978) (77)
- Cloning and Expression of a Novel Hepatitis B Virus-binding Protein from HepG2 Cells* (2001) (76)
- Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation (2003) (72)
- Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia (1998) (71)
- Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B (1982) (71)
- Prevalence and Natural History of Hepatitis C Infection in Patients Cured of Childhood Leukemia (1997) (70)
- Liver cell surface localization of hepatitis B antigen and of immunoglobulins in acute and chronic hepatitis and in liver cirrhosis. (1976) (70)
- Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance (2002) (70)
- Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. (2008) (69)
- Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. The TVVH Study Group. (1993) (69)
- Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective study. (1997) (69)
- Genotypes of hepatitis C virus in Italian patients with chronic hepatitis C (1994) (68)
- Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants (1995) (68)
- Hepatitis B virus precore/core variation and interferon therapy (1995) (68)
- Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon‐α (1995) (68)
- Antibody to hepatitis C virus and liver disease in volunteer blood donors. (1991) (68)
- Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon. (2000) (67)
- Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 49 5 patients with chronic hepatitis C (1995) (65)
- Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. (1991) (65)
- Coinfection by hepatitis B virus and hepatitis C virus. (1998) (65)
- Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases (2007) (64)
- An Antibody Which Precipitates Dane Particles in Acute Hepatitis Type B: Relation to Receptor Sites Which Bind Polymerized Human Serum Albumin on Virus Particles (1984) (64)
- Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. (2010) (63)
- Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance (2004) (63)
- T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infection (1977) (63)
- Effect of Retreatment with Interferon Alone or Interferon plus Ribavirin on Hepatitis C Virus Quasispecies Diversification in Nonresponder Patients with Chronic Hepatitis C (1999) (63)
- Long‐term follow‐up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver‐related complications (2007) (63)
- ANTIBODY RESPONSE TO PRE-S2 AND HEPATITIS B VIRUS INDUCED LIVER DAMAGE (1988) (63)
- Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2 alpha. (1994) (61)
- Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. (1997) (60)
- Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous daa failure. (2019) (60)
- LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN: INTERIM ANALYSIS OF THE EXTEND STUDY (2010) (59)
- Serum levels of soluble CD30 in chronic hepatitis B virus infection (1996) (58)
- Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. (1991) (57)
- Patterns of antibodies to hepatitis C virus in patients with chronic non‐A, non‐B hepatitis and their relationship to viral replication and liver disease (1993) (56)
- Antibody to hepatitis C virus in hepatocellular carcinoma (1990) (56)
- Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C (2006) (56)
- How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? (2012) (56)
- Applying a system approach to forecast the total hepatitis C virus‐infected population size: model validation using US data (2011) (55)
- Review article: management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activity (2006) (54)
- Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients. (1986) (54)
- Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party. (1994) (53)
- Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse. (2006) (52)
- Comparison of three algorithms of non‐invasive markers of fibrosis in chronic hepatitis C (2012) (52)
- Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. (1998) (52)
- Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels. (2005) (51)
- Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C. (2004) (51)
- What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C? (2009) (51)
- Natural history of initially mild chronic hepatitis C. (2004) (50)
- Virus-associated receptors for polymerized human serum albumin in acute and in chronic hepatitis B virus infection. (1983) (50)
- Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP) (2010) (50)
- Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. (2001) (50)
- Hepatitis C genotypes in patients with dual hepatitis B and C virus infection (1996) (48)
- Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. (1991) (47)
- PREDICTABILITY BEFORE TRANSPLANT OF HEPATIC COMPLICATIONS FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION (1989) (46)
- Incidence and pattern of "de novo"hepatocellular carcinoma in HCV patients treated with oral DAAs (2016) (46)
- Diagnosis of hepatitis C. Facts and perspectives. (1991) (46)
- Autoantibodies during α‐interferon therapy for chronic hepatitis B (1991) (45)
- Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B. (1989) (45)
- Large‐scale survey of naturally occurring HBV polymerase mutations associated with anti‐HBV drug resistance in untreated patients with chronic hepatitis B (2011) (45)
- Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trial. (1990) (43)
- In vivo translational efficiency of different hepatitis C virus 5′‐UTRs (1997) (43)
- Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. (2013) (43)
- Hepatitis B virus markers in children with acute leukemia: The effect of chemotherapy (1985) (42)
- Differential distribution of hepatitis B core and E antigens in hepatocytes: Analysis by monoclonal antibodies (1986) (42)
- Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis (1997) (41)
- Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group. (1999) (41)
- Full and empty Dane particles in chronic hepatitis B virus infection: Relation to hepatitis B e antigen and presence of liver damage (1978) (41)
- Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis. (1991) (41)
- Prevalence and incidence of cholecystolithiasis in cirrhosis and relation to the etiology of liver disease. (1997) (40)
- Proapoptotic effect of hepatitis C virus CORE protein in transiently transfected cells is enhanced by nuclear localization and is dependent on PKR activation. (2004) (40)
- Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C (2012) (39)
- Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. (2005) (39)
- Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy. (1993) (39)
- Epidemiology of hepatitis C virus infection in seven European Union countries: a critical analysis of the literature. HENCORE Group. (Hepatitis C European Network for Co-operative Research. (2000) (38)
- Parenchymal transforming growth factor beta‐1: Its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology (2003) (38)
- Increased incidence of liver cancer after successful DAA treatment of chronic hepatitis C: Fact or fiction? (2017) (38)
- In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis. (1986) (37)
- Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. (1987) (37)
- Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group. (1996) (37)
- Hyperinsulinaemia reduces the 24‐h virological response to PEG‐interferon therapy in patients with chronic hepatitis C and insulin resistance (2009) (37)
- Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion. (1996) (36)
- Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. (1995) (36)
- Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop. (2011) (36)
- Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis. (2008) (35)
- Digestive and Liver Disease (2011) (35)
- Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2A interferon. (2008) (35)
- Hepatitis B virus binds to peripheral blood mononuclear cells via the pre S1 protein. (1991) (35)
- Antibodies to the Surface of Halothane-Altered Rabbit Hepatocytes in Patients with Severe Halothane-Associated Hepatitis (1981) (35)
- Double‐blind, randomized controlled trial of interleukin‐2 treatment of chronic hepatitis B (1998) (34)
- Chronic hepatitis type B in childhood: longitudinal study of 35 cases. (1981) (34)
- Chronic hepatitis B: a critical appraisal of current approaches to therapy. (2006) (34)
- Chronic hepatitis C: Interferon retreatment of relapsers. A meta‐analysis of individual patient data (1999) (34)
- Microsomal triglyceride transfer protein polymorphism (−493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C (2009) (33)
- Changes in hepatitis Be antigen/antibody system in children with chronic hepatitis B virus infection. (1983) (33)
- Immune-complexes and Australia antigen in cryoglobulinemic sera. (1974) (32)
- Core antigen-specific immunoglobulin G bound to the liver cell membrane in chronic hepatitis B. (1982) (32)
- Evidence for sequence selection within the non‐structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon‐α (1999) (32)
- Levamisole therapy in chronic type B hepatitis. Results of a double-blind randomized trial. (1986) (32)
- Significance of anti‐HBx antibodies in hepatitis B virus infection (1991) (31)
- Relationship between membrane-bound immunoglobulin and viral antigens in liver cells from patients with hepatitis B virus infection. (1979) (29)
- A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2. (2001) (29)
- Acute and chronic hepatitis in childhood leukemia: a multicentric study from the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP). (1985) (29)
- Hepatitis C virus genotypes and severity of chronic liver disease in haemophiliacs (1995) (28)
- Therapy for chronic hepatitis B with lymphoblastoid interferon‐α and levamisole (1992) (28)
- Human immunodeficiency virus infection and hepatitis C pathology. (2008) (28)
- Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma. (2016) (28)
- Impact of a sustained virological response on the long‐term outcome of hepatitis C (2011) (27)
- Changes in hepatitis B virus DNA‐polymerase activity in patients with chronic infection (1981) (27)
- Effect of Recombinant or Lymphoblastoid Interferon-α on Alanine Aminotransferase in Patients with Chronic Hepatitis C or Chronic Non-A Non-B Hepatitis (1995) (27)
- Detection of hepatitis B virus DNA sequences in bone marrow of children with leukemia (1987) (27)
- Latent hepatitis B virus infection in childhood hepatocellular carcinoma analysis by polymerase chain reaction (1992) (26)
- Evidence of non-A, non-B hepatitis in children with acute leukemia and chronic liver disease. (1983) (26)
- Fine specificity of human antibody response to the pres1 domain of hepatitis B virus (1990) (25)
- Relationship between HBcAg in serum and liver and HBV replication in patients with HBsAg‐positive chronic liver disease (1985) (25)
- Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy. (2012) (25)
- Effects of human leucocyte interferon on hepatitis B virus replication and immune responses in patients with chronic hepatitis B infection. (1979) (24)
- Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort (2017) (24)
- The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis C (2000) (24)
- Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B. (1979) (23)
- Literature review of the distribution of hepatitis C virus genotypes across Europe (2016) (23)
- HBV therapy: guidelines and open issues. (2011) (23)
- POST-TRANSFUSION HEPATITIS IN ITALY (1982) (23)
- Outcome of Acute Hepatitis C and Role of Alpha Interferon Therapy (1994) (23)
- Ultrastructural changes in the liver of patients with chronic non‐A, non‐B hepatitis (1981) (23)
- Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon‐based therapy: FUNDAMENTAL, a Phase II trial (2015) (22)
- 780 PREDICTORS OF SVR IN NAIVE HCV G1 PATIENTS IN REAL LIFE PRACTICE: THE PROBE (2008) (22)
- Antibody to the hepatitis B virus receptor for polymerized albumin in acute infection and in hepatitis B vaccine recipients. (1986) (22)
- Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B. (1981) (21)
- In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma. (2015) (21)
- Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication. (1990) (21)
- Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types. (1995) (21)
- Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma. (1998) (21)
- Antibodies to the RNase H domain of hepatitis B virus P protein are associated with ongoing viral replication (1990) (20)
- Hepatitis C virus serum markers and liver disease in children with leukemia. (1995) (20)
- Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression. (2021) (20)
- Reciprocal interference between insulin and interferon‐alpha signaling in hepatic cells: A vicious circle of clinical significance? (2011) (20)
- Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirin. (2007) (19)
- Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma. (2002) (19)
- Evolution of Hepatitis C Virus Quasispecies in Children with Chronic Hepatitis C (2006) (19)
- Detection by immunofluorescence of an antigen-antibody system in patients with acute and chronic non-A, non-B hepatitis. (2008) (18)
- Prognostic value of hepatitis B core antigen (HBcAg) expression in the liver of children with chronic hepatitis type B. (2008) (18)
- High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders. (2001) (18)
- Hepatitis C virus genotypes HCV-1a and HCV-1b: the clinical point of view. (1995) (18)
- Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study. (2017) (17)
- HBV-DNA sequences are rarely detected in the liver of patients with HBsAg-negative chronic active liver disease and with hepatocellular carcinoma in Italy. (2008) (17)
- Receptors for polymerized human serum albumin on hepatitis B virus particles detected by radioimmunoassay: changes in receptor activity in serum during acute and chronic infection. (1983) (17)
- Do single nucleotide mutations result in clinically significant changes in hepatitis B virus pathogenicity? (1990) (16)
- Heterogeneity of CK2 phosphorylation sites in the NS5A protein of different hepatitis C virus genotypes. (2007) (16)
- Recent progress and new trends in the treatment of hepatitis B (2002) (16)
- Hepatitis C virus infection associated with human hepatocellular carcinoma (1998) (16)
- Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection (2007) (16)
- Nature and display of hepatitis B virus envelope proteins and the humoral immune response (2004) (16)
- Who is more likely to respond to dual treatment with pegylated‐interferon and ribavirin for chronic hepatitis C? A gender‐oriented analysis (2013) (16)
- Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage. (1978) (16)
- Anti-LSP antibodies in acute liver disease. (1982) (15)
- Detailed analysis of the E2–IgM complex in hepatitis C‐related type II mixed cryoglobulinaemia (2006) (15)
- Interferon β-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C (2005) (15)
- Barriers to effective management of hepatitis C virus in people who inject drugs: Evidence from outpatient clinics. (2019) (15)
- Autoantibodies during alpha-interferon therapy for chronic hepatitis B. (1991) (15)
- Interferon therapy for the anti-HBe positive form of chronic hepatitis B. (1994) (15)
- Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett’s esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population (2016) (15)
- A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B. (1994) (15)
- Hepatitis B virus (HBV)‐DNA‐positive hepatocellular carcinoma following hepatitis B virus infection in a child (1987) (15)
- Serum procollagen type III peptide in chronic hepatitis B (1996) (15)
- 1406 ALISPORIVIR (ALV) PLUS PEG-INTERFERON/RIBAVIRIN (PR) IN HCV G1 TREATMENT-EXPERIENCED PATIENTS ACHIEVES PRIMARY ENDPOINT WITH SUPERIOR EFFICACY AT TREATMENT WEEK 12 COMPARED TO RETREATMENT WITH PR (2012) (14)
- Expression of preS1 and preS2 in the liver of chronic hepatitis B virus carriers. (1988) (14)
- Hepatitis C virus serotypes and liver pathology. (2008) (14)
- Predictive value of alt levels on histological findings in chronic hepatitis C: a European collaborative study (2001) (14)
- Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation (1997) (14)
- Natural killer activity in patients with acute viral hepatitis. (1986) (14)
- Long-term evolution of chronic hepatitis B in children with antibody to hepatitis B e antigen. (1990) (14)
- Protease inhibitors‐based therapy induces acquired spherocytic‐like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients (2016) (14)
- Cellular immunity to the hepatitis B virion in acute hepatitis type B. (1983) (13)
- Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model (2018) (13)
- Selection of a precore mutant of hepatitis B virus and reactivation of chronic hepatitis B acquired in childhood. (1993) (13)
- Polyalbumin receptors on hepatitis B virus and on 22 nm hepatitis B surface antigen (H BsAg)2 particles (1984) (13)
- PRE-S2 ANTIBODIES IN HEPATITIS B (1986) (13)
- Risk factors and prevention of hepatocellular carcinoma in HCV infection (1996) (13)
- Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed? (2004) (13)
- Antibody to hepatitis C virus in cryptogenic chronic liver disease (1991) (13)
- Pkr Gene Expression and Response to Pegylated Interferon plus Ribavirin Therapy in Chronic Hepatitis C (2004) (12)
- ANTIBODIES TO HEPATITIS C VIRUS IN CHILDREN WITH ACUTE OR CHRONIC VIRAL HEPATITIS (1989) (12)
- Pilot study of interferon alpha-2a therapy in preventing chronic evolution of acute hepatitis C (1990) (12)
- Serum hepatitis B virus DNA in acute hepatitis type B. (1986) (12)
- Can serum HBV‐DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B? (2003) (12)
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of data from European Centers. (1997) (11)
- Detection of fluorescent organic nanoparticles by confocal laser endomicroscopy in a rat model of Barrett’s esophageal adenocarcinoma (2015) (11)
- HBAg ON LIVER-CELL SURFACE IN VIRAL HEPATITIS (1975) (11)
- The evolution of the therapeutic strategy in hepatitis C: features of sofosbuvir and indications. (2014) (11)
- The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group. (2000) (10)
- Virus receptors for polymerized human serum albumin and anti-receptor antibody in hepatitis B virus infection. (1983) (10)
- 829 EFFECTIVENESS OF HEPATITIS C VIRUS TREATMENT IN REAL-LIFE PRACTICE: A PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY IN ITALY (PROBE) (2008) (10)
- Virus receptors for polymerized human albumin: A prognostic marker in HBeAg‐positive chronic hepatitis type B? (1982) (10)
- Different mechanisms responsible for in vitro cell-mediated cytotoxicity to autologous hepatocytes in children with autoimmune and HBsAg-positive chronic liver disease. (1985) (10)
- Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B. (1992) (10)
- A 7 year survey of acute hepatitis type B. (1983) (10)
- The dilemma for patients with chronic hepatitis C: treat now or warehouse? (2014) (10)
- Comparable performance of TMA and Real-Time PCR in detecting minimal residual hepatitis C viraemia at the end of antiviral therapy. (2011) (10)
- Virus replication and liver disease in chronic hepatitis B virus infection (1983) (9)
- TREATMENT OF CHRONIC HEPATITIS C WITH DIFFERENT REGIMENS OF INTERFERON ALPHA-2a (IFN-2a) (1993) (9)
- Real life experiences in HCV management in 2018 (2019) (9)
- Expression of HBsAg on the membrane of hepatocytes in chronic carriers of hepatitis B virus infection. (1978) (9)
- Comparison of thrice weekly vs daily human leucocyte interferon‐α therapy for chronic hepatitis C (1999) (9)
- Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: Studies in hepatic and non-hepatic diseases (1975) (9)
- Treatment of chronic hepatitis B: Update of the recommendations from the 2007 (2011) (9)
- Does hepatitis B virus play a role in primary liver cancer in children of Western countries? (1991) (9)
- Hepatitis viruses as aetiological agents of hepatocellular carcinoma. (1991) (9)
- Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies (2000) (9)
- Hepatitis C virus quasispecies in the natural course of HCV‐related disease in patients with haemophilia (2004) (9)
- Pilot study on the efficacy of intravenous natural β-interferon therapy in Italian patients with chronic hepatitis C and relation to the HCV genotype (1995) (8)
- HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study (2016) (8)
- [483] PRESENCE OF BIOPSY-PROVEN HISTOLOGIC DAMAGE (NECROINFLAMMATION AND FIBROSIS) IS COMMON EVEN WHEN ALT IS LESS THAN 2 × ULN IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) (2007) (8)
- Hepatitis B virus DNA forms in the liver of chronically infected individuals. Relation to replication profile. (1989) (8)
- Treatment of chronic hepatitis C with interferon‐α by monitoring the response according to viraemia (1997) (8)
- Cytokeratins patterns in childhood primary liver tumors (1993) (8)
- Cryptogenic chronic liver disease and serum or liver hepatitis B virus markers. Their possible correlations and etiologic significance. (1988) (8)
- Chronic evolution of acute hepatitis type B: Prevalence and predictive markers (1986) (8)
- Evidence against the role of hepatitis C virus in severe liver damage occurring early in the course of acute leukemia in children. (1994) (8)
- Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis (1989) (8)
- Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C. (2005) (8)
- Virological changes in chronic hepatitis type B treated with levamisole. (1982) (7)
- Cell-mediated immunity to HBcAg in chronic HBV infection. (1987) (7)
- Interferon alfacon-1: a novel interferon for the treatment of chronic hepatitis C. (1999) (7)
- Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program (2019) (7)
- Interferon Alfacon-1 (1999) (7)
- Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy (2016) (7)
- Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis. (2017) (7)
- Variables that influence response to different interferon schedules in chronic hepatitis C and predictive models (1997) (6)
- Radioimmunoassay for Hepatitis B ‘e'Antigen and Antibody: Correlations with Viral Replication and Prognostic Value (1981) (6)
- Implementing non-invasive markers for liver fibrosis in clinical practice. (2008) (6)
- The natural history of post-transfusion and sporadic non-A, non-B, hepatitis in Italy. (1983) (6)
- Hepatitis C virus infection in chronic hepatitis B (1990) (6)
- Core Protein Evolution After Selection of Hepatitis B Precore Mutants and Correlation with Disease Severity (1994) (6)
- Pattern of Liver Disease Following High-Dose Cytosine Arabinoside (HDARAC) Therapy in Children with Acute Myeloid Leukemia. (1990) (6)
- Antibody to pre‐S antigens in hepatitis B virus infection (1987) (6)
- Retreatment of chronic hepatitis C (CHC) with sequential interferon-ribavirin combination (IFN-RIBA) therapy (1998) (6)
- Hepatitis B core antigen (HBcAg) in serum of patients with chronic hepatitis B detected by a modified radioimmunoassay (1985) (6)
- Methods for the study of pre-S proteins of hepatitis B virus and their antibodies: pathogenetic and clinical implications (1988) (6)
- Reverse transcriptase activity in post-transfusion non-A, non-B hepatitis: I. Characterisation and association with retrovirus-like particles in serum (1987) (6)
- Polymerase-chain-reaction-based semi-quantification of hepatitis D viraemia in patients treated with high doses of α2b interferon (1994) (5)
- Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: The interim analysis of the ANSWER study (2015) (5)
- IgM antibodies to hepatitis C virus (1994) (5)
- In vitro effect of lymphoblastoid alpha-interferon on subpopulations of effector cells mediating cytotoxicity for autologous hepatocytes in hepatitis B and non-A, non-B. (1986) (5)
- Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response (1998) (5)
- IgM antibody to hepatitis B core antigen in children with chronic type B hepatitis (1987) (5)
- Chronic hepatitis C : natural history and cofactors (2005) (5)
- Guidelines for the treatment of chronic viral hepatitis (1997) (5)
- The role of PreS1 in the interaction of hepatitis B virus with human hepatocytes (1991) (5)
- Corrigendum to “SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS”[J Hepatol 42 (2005) 615–624] (2005) (5)
- Polymerase-chain-reaction-based semi-quantification of hepatitis D viraemia in patients treated with high doses of alpha 2b interferon. (1994) (5)
- Natural History of Hepatitis C and Prognostic Factors of Disease Progression (2004) (5)
- Anti-interferon antibodies during interferon therapy for chronic hepatitis C. (1994) (5)
- Pre-core HBV mutants: Response to interferon therapy (1991) (5)
- Use of ustekinumab in five psoriatic patients with hepatitis B virus infection. (2019) (5)
- Chronic hepatitis B: a controlled trial of thymopentin therapy in HBV-DNA positive patients (1992) (5)
- Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole. (1992) (5)
- Interferon-ribavirin combination therapy for chronic hepatitis C (1996) (5)
- Natural history of chronic hepatitis B (2004) (5)
- Human leucocyte interferon-alpha in the treatment of chronic hepatitis C. (2001) (5)
- Impact of NS 5 A Sequences of Hepatitis C Virus Genotype 1 a on Early Viral Kinetics during Treatment with Peginterferon-a 2 a plus Ribavirin (2007) (4)
- HCC recurrence under all-oral DAAs-based antiviral therapy in HCV-infected patients: data from Navigatore web platform (2018) (4)
- Specificity and patterns of antibodies to hepatitis C virus in hepatocellular carcinoma (1991) (4)
- Levamisole therapy in chronic type hepatitis. (1988) (4)
- Does hepatitis B virus cross the blood-brain barrier? (1986) (4)
- Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection (2017) (4)
- Transcatheter arterial embolisation versus no treatment in cirrhotic patients with hepatocellular carcinoma: a retrospective comparative study (1994) (4)
- UEG Week 2016 Poster Presentations (2016) (4)
- P.229 HCV-1 subtypes and response to pegylated interferon plus ribavirin therapy (2006) (4)
- Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection (2013) (4)
- A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions (2022) (4)
- Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study. (2020) (4)
- Liver disease in chronic hepatitis B virus (HBV) infection: relation to HBeAg and anti-HBe status (1983) (4)
- Serum HBV-DNA in anti-HBe positive patients detected by filter and liquid phase hybridization assays. (1989) (4)
- Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B. (1988) (4)
- Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience. (2019) (4)
- 321 A NON-CANONICAL INTERFERON-ALPHA PATHWAY, THROUGH IRS1, MIGHT BE INVOLVED IN THE REDUCED ANTIVIRAL THERAPY RESPONSE IN PATIENTS WITH INSULIN RESISTANCE AND CHRONIC HEPATITIS C (2009) (4)
- Liver-specific autoantibodies in chronic hepatitis B virus infection. (1985) (4)
- Hepatitis C virus infection in hemodialyzed patients detected by first and second generation assays. (1992) (4)
- Correspondence. Intranuclear Particles in Non‐A, Non‐B Hepatitis (1984) (3)
- Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study (2016) (3)
- Hepatitis B virus infection markers in chronic liver disease in Italy. The results of a multiregional investigation (1984) (3)
- α-Interferon enhances non-T cell cytotoxicity for autologous hepatocytes in acute and chronic HBV infection (1986) (3)
- Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy (2019) (3)
- For a program of eradication of hepatitis C in the populations at risk (Drug users and convicts) (2018) (3)
- A comparison of cost-effectiveness of peginterferon alfa-2a (40KD) (Pegasys) plus ribavirin (copegus) vs interferon alfa-2b plus ribavirin as first treatment of chronic hepatitus C (CHC) (2003) (3)
- HCV–Related Mixed Cryoglobulinemia: Data from Piter, a Nationwide Italian HCV Cohort Study (2016) (3)
- Hepatitis B virus type 2 in Italian hemophiliacs (1989) (3)
- 756 LARGE-SCALE MULTICENTER COMPARISON OF THREE ALGORITHMS COMBINING SERUM NON-INVASIVE MARKERS FOR LIVER FIBROSIS IN CHRONIC HEPATITIS C (2008) (3)
- [Treatment of cryptogenic chronic liver diseases with recombinant alpha-2a interferon. Preliminary results of a randomized controlled clinical trial]. (1990) (3)
- Lymphoproliferative disease of granular lymphocytes in a patient with concomitant hepatitis B virus infection of CD4 lymphocytes (1989) (3)
- Familial cluster of hepatitis C virus type 1. (1994) (3)
- Hepatitis B and hepatitis C virus infections in stem cell transplantation. (1999) (3)
- Hepatitis C Virus Infection and Replication in Patients with Hepatocellular Carcinoma (1994) (3)
- Clinical trial: comparison of weekly once versus twice half‐dose weekly administration of pegylated interferon alpha 2b in combination with ribavirin for the treatment of HCV‐1 positive patients with chronic hepatitis C (2007) (3)
- Interferon therapy of cryptogenic chronic active liver disease and its relationship to anti-HCV. (1992) (3)
- 1421 ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS) (2013) (3)
- PIN31: THE COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS) PLUS RIBAVIRIN (COPEGUS) VS. INTERFERON ALFA-2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (CHC) (2003) (3)
- HCV treatment policy in a real-life cohort (2017) (3)
- [123] SUSTAINED VIROLOGICAL RESPONSE RATES WITH PEGINTERFERON a-2a (40 kD) (PEGASYS®) PLUS RIBAVIRIN (COPEGUS®) IN RANDOMISED CONTROLLED CLINICAL TRIALS ARE REPLICATED IN THE CLINICAL PRACTICE SETTING (2007) (2)
- Reverse transcriptase activity in post-transfusion non-A, non-B hepatitis: II. Relation to liver disease activity and long-term outcome (1987) (2)
- Space-occupying lesions of the liver detected by ultrasonography and their relation to hepatocellular carcinoma in cirrhosis. (2008) (2)
- Favourable response to lymphoblastoid interferon of anti-HBe and HBV-DNA positive chronic hepatitis B (1990) (2)
- CORRELATION OF HCV RNA TO TOTAL HCV CORE ANTIGEN IN CHRONIC HEPATITIS C PATIENTS (2002) (2)
- ANTIBODY TO THE POLYALBUMIN (pHSA) RECEPTOR ON HEPATITIS B VIRUS IN ACUTE INFECTION AND IN VACCINE RECIPIENTS (1985) (2)
- 15 Open, multicenter, randomized, controlled trial to compare safety and efficacy of r-hIFN beta 1a alone or in combination with ribavirin in HCV naiv patients (2003) (2)
- A cirrhosis risk score identifies those chronic hepatitis C infected patients presenting with no liver fibrosis that are at high risk for fibrosis progression (2007) (2)
- Detection of hepatitis B virus pre-S1 and pre-S2 determinants in paraffin wax embedded liver tissue: importance of reagents used. (1991) (2)
- Prevalence and significance of hepatic steatosis in hepatitis C (2003) (2)
- World gastroenterology organisation practice guideline - hepatitis B September 2008 (2009) (2)
- Relevance of serum HBV-DNA in acute and chronic hepatitis type B (1985) (2)
- [566] PRE-TREATMENT FACTORS PREDICTING SUSTAINED VIROLOGICAL RESPONSE IN TREATMENT-NAIVE HCV GENOTYPE 1 PATIENTS PARTICIPATING IN A LARGE, PRACTICE-BASED NATIONWIDE OBSERVATIONAL STUDY (2007) (2)
- PREDICTION OF OESOPHAGEAL VARICES (OV) IN HEPATIC CIRRHOSIS BY SERUM NON-INVASIVE MARKERS: RESULTS OF A MULTICENTER, INTERNATIONAL STUDY (2009) (2)
- O.064 Antiviral treatment for hepatitis C virus infection in the real practice: A nationwide Italian experience (the PROBE study) (2006) (2)
- A MODEL TO PREDICT SUSTAINED RESPONSE TO THERAPY AND TO OPTIMIZE THE DOSE OF INTERFERON IN CHRONIC HEPATITIS C (1995) (2)
- Chronic hepatitis C without antibody to C-100 (1991) (2)
- Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection: response to Lecube et al. (2005) (2)
- Hepatitis B virus binds to IgA receptors of liver cells (1990) (2)
- 741 GENOTYPE-SPECIFIC MUTATIONS IN THE RT REGION OF HBV POLYMERASE POTENTIALLY ASSOCIATED TO DEVELOPMENT AND EVOLUTION OF RESISTANCE TO ORAL ANTIVIRAL THERAPY (2011) (2)
- Anti-HBe and HBV-DNA positive chronic hepatitis B: Response to interferon therapy (1989) (2)
- Prospective study of hepatocellular carcinoma (HCC) in patients with cirrhosis (1993) (2)
- Subliminal virus replication is chronic hepatitis type B: Detection by PCR (1991) (2)
- A model to predict long‐term sustained response to interferon therapy in chronic hepatitis C (1997) (2)
- HBeAg and anti-HBe in chronic hepatitis B virus infection (1981) (2)
- Randomized controlled trial of interferon therapy as chemoprevention of HCC in HCV related cirrhosis (2001) (2)
- Prediction of oesophageal varices in hepatic cirrhosis by using simple non-invasive markers: Results of a multicentre, international study (2008) (2)
- Evidence for reduced rates of quasispecies diversification during combination interferon plus ribavirin therapy for chronic hepatitis C (1998) (2)
- THU-131-Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: A real-life study from the NAVIGATORE Lombardia and Veneto Networks (2019) (2)
- [Pityriasis rotunda: study of 2 family groups. Preliminary report]. (1988) (1)
- STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS * (2005) (1)
- HER2 overexpression is a suitable marker for “in vivo” targeted confocal endoscopy in a rat model of Barrett's Esophagus carcinogenesis (2012) (1)
- Interpreting liver stiffness in the cirrhotic range: What are we measuring? (2009) (1)
- Monoclonal Radioimmunoassay for Hepatitis B Surface Antigen in Sera of Children With Acute Leukemia (1986) (1)
- OC.10.1 TARGETED CONFOCAL ENDOMICROSCOPY FOR IN VIVO MOLECULAR IMAGING OF HER2 IN A RAT MODEL OF BARRETT'S ESOPHAGUS CARCINOGENESIS (2013) (1)
- THU-141-Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients (2019) (1)
- Therapeutic value and innovation of a drug and criteria for evaluation: A multidisciplinary experience in the Veneto Region (2015) (1)
- Retrospective analysis of the effect of interferon therapy on hepatocellular carcinoma (HCC) development in cirrhosis (1996) (1)
- 473 Diagnostic performance of noninvasive biomarkers of liver fibrosis and cirrhosis in chronic hepatitis B (2006) (1)
- Intranuclear particles in non-A, non-B hepatitis. (1984) (1)
- Vitamin E does not reduce ribavirin associated anaemia during combination therapy for hepatitis C (2002) (1)
- Diabetes Is the Main Factor Accounting for the High Ferritin Levels Detected in Chronic Hepatitis C Virus Infection Response to Lecube et al. (2005) (1)
- Anti-HCV and liver disease in Italy in the last 10 years (1989) (1)
- Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients (2019) (1)
- Metabolic cofactors play an important role in fibrosis progression in initially mild chronic hepatitis C (2002) (1)
- Cost Effectiveness Analysis of The Use of Daclatasvir for the Treatment of Hepatitis C Virus (Hcv) Genotypes 3 in Cirrhotic Patients Within the Italian National Health Service. (2015) (1)
- The genotype of hepatitis C virus does not affect severity of liver disease after bone marrow transplantation. (1995) (1)
- Combination therapy with lymphoblastoid interferon and levamisole in chronic hepatitis type B (1991) (1)
- Localisation of PKR and HCV-NS5A in living cells using fusion proteins with different mutants of GFP (2002) (1)
- Influence of hepatitis delta virus infection on progression to cirrhosis of anti-HBe positive chronic active hepatitis (1987) (1)
- Confirmatory tests for antibody to hepatitis C virus (1990) (1)
- Presence of Biopsy-Proven Histologic Damage (Necroinflammation and Fibrosis) is Common Even When ALT is Less Than 2 x ULN in Patients with Chronic Hepatitis B (CHB) in Entecavir Studies ETV-022 (HBeAg+) and ETV-027 (HBeAg-) (2007) (1)
- SERUM MARKERS OF HEPATIC FIBROGENESIS IN CHRONIC HEPATITIS TYPE C TREATED WITH INTERFERON (1992) (1)
- Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus. (2018) (1)
- Serum binding activity for polymerized human albumin due to antibodies detected by enzyme-linked immunosorbent assay in acute and chronic type B, A and NANB viral hepatitis (1987) (1)
- Large scale validation of the safe (sequential algorithms for fibrosis evaluation) biopsy in chronic hepatitis C (2007) (1)
- Combination of non invasive markers to identify liver fibrosis in HCV patients with persistently normal ALT (PNALT) (2005) (1)
- 242 Natural history of untreated hepatocellular carcinoma (HCC) on cirrhosis: Survival analysis and prognostic factors in 559 patients (2006) (1)
- Viral hepatitis. (1991) (1)
- Acquired spherocytic like anemia combined with ineffective erythropoiesis sustains anemia in patients with chronic hepatitis C infection receiving telaprevir or boceprevir-based triple therapy (2015) (1)
- THU-166-Treatment of 320 genotype 3 cirrhotic patients with 12 weeks of sofosbuvir/velpatasvir with or without ribavirin: Real life experience from Italy (2019) (1)
- [Presence of HBsAg and IgG on the membrane of hepatic cells in patients with acute and chronic hepatitis]. (1976) (1)
- Hepatitis B surface antigen clearance during hepatitis C virus infection (1990) (1)
- Subject Index, Vol. 39, 1988 (1988) (1)
- Mutation of HBcAg after loss of HBeAg and association with progressive disease (1992) (1)
- Clinical Features and Diagnostic Markers in Non-A, Non-B Hepatitis1 (1984) (0)
- Detection of HBV-DNA by PCR in serum and liver during the follow up of HBsAg positive transplanted patients receiving hepatitis B immunoglobulin prophylaxis (1995) (0)
- SQUAMOUS CELL CARCINOMA ANTIGEN VARIANTS OVEREXPRESSION IN HEPATOCELLULAR CARCINOMA. (2004) (0)
- Hepatitis B virus infection and liver disease in patients undergoing bone marrow transplantation (BMT) (1989) (0)
- Evidence for virus interference among hepatitis B,C and D viruses (1992) (0)
- Childhood Leukemia Prevalence and Natural History of Hepatitis C Infection in Patients Cured of (2013) (0)
- Treatment of chronic hepatitis C with persistently normal alanine aminotransferase levels (2010) (0)
- The effect of peginterferon alfa-2a (40 KD) on liver histology in chronic hepatitis C: A meta-analysis of individual patients data (2003) (0)
- Influence of HBAg on T limphocytes in acute viral hepatitis. (1975) (0)
- Reply: (2009) (0)
- Virus-associated receptor for polymerized human serum albumin and antibody to the receptor in HBV and in HDV infection. (1987) (0)
- 167 DONOR/RECIPIENT SEVEN GENE SIGNATURE (CIRRHOSIS RISK SCORE) AND DONOR AGE AS PREDICTORS OF LIVER FIBROSIS PROGRESSION DUE TO HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION (2013) (0)
- Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern Italy (2020) (0)
- HCV GENOTYPES AND INTRAFAMILIAL SPREADING OF HCV INFECTION (1995) (0)
- Long term follow-up of anti-HBe/anti-HCV positive, HBV-DNA/HDV negative patients with chronic hepatitis (1990) (0)
- Osseo (GITMO) multicenter study from the Gruppo Italiano Trapianto di Midollo Allogeneic bone marrow transplantation from HBsAg+ donors: a (2011) (0)
- Prospective study of hepato-cellular carcinoma (HCC) development in cirrhosis of viral etiology (1991) (0)
- Budget Impact Analysis Of Sofosbuvir For The Treatment Of Hepatitis C In The Veneto Region, Italy. (2014) (0)
- DETECTION OF HIDDEN HEPATITIS B CORE ANTIGEN (HBcAg) IN SERUM IN ACUTE AND CHRONIC HEPATITIS B VIRUS (HBV) INFECTION (1985) (0)
- Characterization of Polymerized Human Serum Albumin Binding Activity in Acute and Chronic Viral Hepatitis Types B,a,nanb (1985) (0)
- Neurotoxychological Monitoring of Interferon treatment in Viral Hepatitis: a Pilot Sudy (2001) (0)
- Antibodies Against Polymerized Human Serum Albumin Detected by Elisa in Acute and Chronic Viral Hepatitis Types B, A, Nanb (1985) (0)
- Immunofluorescence tests in non-A, non-B hepatitis. (2008) (0)
- [Immunologic mechanisms of cell damage and pathogenetic correlations in acute and chronic hepatitis]. (1978) (0)
- Sequence of NS5A2209–2248 region of hepatitis C virus in hepatocellular carcinoma (2000) (0)
- Cognitive effects of long-term interferon treatment for chronic viral hepatitis (2003) (0)
- Chronic hepatitis typeBinchildhood: longitudinal study of35cases (1981) (0)
- LYMPHOPROLIFERATIVE DISEASE ASSOCIATED TO HEPATITIS B VIRUS (HBV) INFECTION OF CD4+ T LYMPHOCYTES (1988) (0)
- Virus and Host Factors in the Evolution of Chronic Hepatitis Type B: Choice of Treatment (1987) (0)
- P1158 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM (2014) (0)
- A prospective study comparing two algorithms that combine non-invasive methods for liver fibrosis in chronic hepatitis C (2008) (0)
- Levamisole in combination with lymphoblastoid alpha interferon in the treatment of chronic hepatitis B (1993) (0)
- The role of hepatitis C virus in acute and chronic liver disease. (1992) (0)
- Alpha-interferon enhances non-T cell cytotoxicity for autologous hepatocytes in acute and chronic HBV infection. (1986) (0)
- LARGE SCALE SURVEY OF NATURALLY OCCURING HBV POLYMERASE MUTATIONS ASSOCIATED WITH ANTI-HBV DRUG RESISTANCE IN NUCLEOS(T)IDE ANALOGUE- NAIVE PATIENTS WITH CHRONIC HEPATITIS B (2010) (0)
- Early anti-HCV Seroconversion in post-transfusion hepatitis (PTH) (1990) (0)
- T-26 Long-term FU of patients with CHC treated with telaprevir in combination with PEG-IFN alfa-2a and RBV: Interim analysis of the EXTEND study (2011) (0)
- A CONTROLLED TRIAL OF LYMPHOBLASTOID INTERFERON FOR CHRONIC ANTI- HBE/HBV-DNA POSITIVE HEPATITIS (1988) (0)
- 519 Long-term occurrence of liver complications in hepatitis C patients. Association with host and viral factors (2004) (0)
- Serum and tissue expression of the hepatitis B virus genome in chronic infection and its relation to liver pathology (1989) (0)
- 395 Evidence that the monoclonal component of type II mixed cryoglobulinemia is direct against HCV (E2) determinants (2004) (0)
- 460 Interferon (IFN) therapy has little effect on progression of portal hypertension in hepatitis C virus (HCV) related cirrhosis (2004) (0)
- Estimate of fibrosis progression during chronic hepatitis C (CHC) in north-east Italy (2000) (0)
- 23 The effect of peginterferon alfa-2a (40KD) on liver histology in chronic hepatitis C: A meta-analysis of individual patients data (MIPD) (2003) (0)
- Virus interference in patients with multiple B, D and C infection (1992) (0)
- Timing and dose effect of alpha-interferon on early viral kinetics in chronic hepatitis C (1998) (0)
- Recombinant interferon alfa-2a in cryptogenic chronic active liver disease (1990) (0)
- HCV SEROTYPE AND PATHOGENESIS OF LIVER-DISEASE (1995) (0)
- Anti-HCV in cryptogenic acute and chronic hepatitis (1990) (0)
- Non‐invasive algorithms for liver fibrosis: authors’ reply (2012) (0)
- Sequence analysis of two PKR inhibitor HCV proteins in patients treated with high doses of interferon (2000) (0)
- Prevalence of a 660 amino acid substitution in the PePHD region of HCV-E2 protein in hepatocellular carcinoma (2002) (0)
- Efficacy and safety of oral DAAs HCV therapy in the elderly (2016) (0)
- 280 Diabetes mellitus accellerates the development of hepatocellular carcinoma (HCC) in alcohol-related but not in virus-related chronic liver disease (2006) (0)
- Antibodies to structural and non-structural hepatitis C virus epitopes in acute infection (1991) (0)
- Changes of anti-HCV antibodies in chronic hepatitis C during interferon therapy (1991) (0)
- Persistent HBV infection in HBeAg negative active liver disease is associated with aminoacid substitutions in B and T-helper cell epitopes rather than in CTL epitopes (1994) (0)
- Two distinct patterns of alanine aminotransferase (ALT) reflecting different levels of immunocompetence in chronic hepatitis type B (1984) (0)
- A controlled trial of thymopentin therapy in HBV-DNA positive chronic hepatitis B (1992) (0)
- Serum hepatitis C virus RNA during follow up of patients with acute sporadic and parentally acouired NANB hepatitis (1991) (0)
- Carman, W F see Jazayeri, M. Carnot, F see Lebray, P. Caronia, S, McGarvey, M J, Goldin, R D &. Foster, G R. Negative correlation between intrahepatic expression of hepatitis C antigens and apoptosis despite high-level expression of Fas ... (2004) (0)
- Soluble fas, TNF-RI and TNF-RII in hepatitis C virus infection with and without extrahepatic manifestations (1998) (0)
- F-42 Gender-specific determinants of response in HCV genotype 1 to current SOC with peg IFN and ribavirin in a practice cohort (2012) (0)
- CHARACTERIZATION OF LIVER HBV-DNA FORMS ASSOCIATED WITH HBeAg TO ANTI-HBe SEROCONVERSION (1986) (0)
- Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study Group (2018) (0)
- Epidemiology of acute sporadic nanb hepatitis (1990) (0)
- Hepatocyte bound immunoglobulin in hepatitis B infection. (1979) (0)
- Circulating hepatocyte membrane-specific autoantibodies in chronic active hepatitis type B (1984) (0)
- Anti-LSP antibody in acute viral hepatitis (1978) (0)
- [Humoral and cellular immunoreactions against HBsAg and liver-specific proteins in the course of acute and chronic hepatitis]. (1976) (0)
- 230 Clinical features and response to interferon in patients with different HCV genotypes in Italy (1993) (0)
- disease after bone marrow transplantation (letter; comment) The genotype of hepatitis C virus does not affect severity of liver (2013) (0)
- A controlled trial of alpha-2 recombinant interferon for chronic HBeAg positive hepatitis (1988) (0)
- [567] HCV HEPATITIS AND INTERFERON-RELATED DEPRESSION: AN ANALYSIS OF THE RETROSPECTIVE PHASE OF THE PROBE STUDY (2007) (0)
- [Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study]. (1975) (0)
- The prognosis of chronic persistent hepatitis: a clinical and morphological follow-up study (1988) (0)
- Survival in untreated and treated patients with HCC on cirrhosis according to the stage and treatment procedure: analysis of 1187 cases. (2004) (0)
- A randomized controlled clinical trial of recombinant human alpha-2a interferon (IFN) in cryptogenic chronic active liver disease: Preliminary results (1989) (0)
- 34 Anti-HBc positivity and gender are strongly related to HCC but are not related to treatment outcome (2004) (0)
- Treatment prioritization according to the EASL HCV CPG 2015: a real-life evaluation on the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort (2015) (0)
- Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program (2019) (0)
- OC.14.1 IS THE ADHERENCE TO WCRF/AICR RECOMMENDATIONS INVOLVED IN BARRETT'S ESOPHAGUS ONSET AND ITS PROGRESSION TO EAC? A RETROSPECTIVE ANALYSIS IN A HIGH-RISK POPULATION (2018) (0)
- Favourable response to lymphoblastoid interferon of anti-HBe positive chronic hepatitis type B (1990) (0)
- Effect of prevalence of liver fibrosis stages in the performance of non-invasive fibrosis biomarkers in chronic liver diseases (CLDs): Results of an independent, international study (2009) (0)
- Evidence of Hepatitis B Virus Infection in Chronic Hepatitis HBsAg Negative by Conventional Assays (1986) (0)
- Publications - Division of Infectious Diseases & Hospital Epidemology 2005 (2005) (0)
- LATE-BREAKER POSTER ABSTRACTS (2012) (0)
- reatment of chronic hepatitis B : Update of the recommendations from the 2007 talian Workshop (2011) (0)
- [629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP) (2007) (0)
- F5-5 Predictors of response to interferon and therapeutic options in chronic hepatitis C (1995) (0)
- Heterogeneity of antigenic expression at the liver cell surface in hepatitis B virus infection (2008) (0)
- The Pre-S/anti-Pre-S systems represent new markers of the hepatitis B virus (HBV) with potential pathogenetic and clinical relevance (1987) (0)
- Determinants of disease activity and evolution of chronic hepatitis type B. (1987) (0)
- Large-scale multicentre comparison of three algorithms combining serum non-invasive markers for liver fibrosis in chronic hepatitis C (2008) (0)
- Hepatic iron in chronic hepatitis C: The effect of different HCV genotypes (2005) (0)
- Significance of “borderline” reactivity in tests for antibody to hepatitis C virus in blood donors (1991) (0)
- Letters to the Editor Anti-interferon antibodies during interferon therapy for chronic hepatitis C (1994) (0)
- DISCREPANCIES IN ASSESSING HBV REPLICATION BY SERUM HBeAg AND HBV- DNA. THEIR RELATION TO HDV INFECTION (1987) (0)
- HFE gene mutations in liver cirrhosis and hepatocellular carcinoma (2000) (0)
- EVELOPMENT OF A NOMOGRAM BASED ON LINICAL FACTORS FOR PREDICTION OF SIG- IFICANT FIBROSIS IN CHRONIC HEPATITIS C ATIENTS (2009) (0)
- Therapy of acute hepatitis C (2002) (0)
- Treatment of anti-HBe and HBV-DNA positive chronic hepatitis with lymphoblastoid interferon alfa (1991) (0)
- Budget Impact Analysis of The Use of Daclatasvir for The Treatment of Hepatitis C Virus (Hcv) Genotypes 3, In The Italian Setting. (2015) (0)
- Liver, Pancreas and Biliary Tract Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life (2005) (0)
- T-10 Effect of prevalence of fibrosis stages on the performance of non-invasive fibrosis biomarkers in chronic liver diseases (CLDs): Results of a large-scale, international study (2011) (0)
- HBV/HCV coinfection: viral genomic profile of dominant virus (2002) (0)
- Pre-core/core gene variation: correlation with response to interferon and sequence evolution during therapy (1994) (0)
- Infection diseases in the prisons: A public health warming. Priority action to protect general community (2022) (0)
- Low risk of autoimmunity during alpha interferon therapy of chronic hepatitis B (1991) (0)
- [Infection due to hepatitis B virus and host immune response]. (1976) (0)
- Detection ofhepatitis Bvirus pre-SI andpre-S2 determinants inparaffin wax embeddedliver tissue: Importance ofreagentsused (2011) (0)
- HEPATOCELLULAR CARCINOMA IN HBsAg NEGATIVE CHILDREN (1991) (0)
- The pre S1 domain is the attachment site of hepatitis B virus to host cell membranes (1989) (0)
- F-25 Prospective validation of noninvasive methods to assess liver fibrosis in HCV patients after liver transplantation (LT) (2012) (0)
- 224 PREDICTION OF OESOPHAGEAL VARICES (OV) IN HEPATIC CIRRHOSIS BY SERUM NON-INVASIVE MARKERS: RESULTS OF A MULTICENTER, INTERNATIONAL STUDY (2009) (0)
- Randomized controlled trial of recombinant alpha 2A-interferon (IFN) in chronic NANB post-transfusion hepatitis (PTH) (1989) (0)
- Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy (2020) (0)
- Sofosbuvir plus ribavirin for difficult to treat HCV-2: improved efficacy with extended treatment duration. (2016) (0)
- 25 Transplantation of bone marrow-derived hepatic stem cells in an animal model of hepatic ischemia/reperfusion injury (2003) (0)
- Antibodies totheRNaseH DomainofHepatitis B VirusP Protein AreAssociated withOngoing Viral Replication (1990) (0)
- Host genetics regulates liver fibrosis progression in patients with chronic hepatitis C (CHC) (2008) (0)
- THE EFFECT OF RE-TREATMENT WITH INTERFERON ALONE OR INTERFERN PLUS RIBAVIRIN ON HCV QUASISPECIES DIVERSIFICATION IN NONRESPONDER PATIENTS WITH CHRONIC HEPATITIS C (1999) (0)
- Hepatocyte bound immunoglobulin in hepatitis B virus infection (1979) (0)
- Molecular diagnostics in hepatitis C virus infection: clinical applications. Scientific Committee--"Tecnologie molecolari nella diagnostica delle epatopatie" of the Italian Association for the Study of the Liver-AISF. (1997) (0)
- Development of a nomogram based on clinical factors for prediction of significant fibrosis in chronic hepatitis C patients (2009) (0)
- Hepatocellular carcinoma (HCC) is the major cause of liver related morbidity and mortality in compensated viral related cirrhosis (2001) (0)
- Liver cell apoptosis in chronic hepatitis C and its relation to necroinflammatory activity, clinic and virologic parameters. (2000) (0)
- 405 HCV NS5A phosphorylation by CK2 is genotype dependent (2006) (0)
- Non-A, Non-B Hepatitis-Reply (1984) (0)
- Low heterogeneity and peculiarity of HCV quasispecies in liver, PBMCS and serum of patients with HCV-related cryoglobulinemic syndrome (2000) (0)
- leukemia in long-term remission Hepatitis C virus infection and chronic liver disease in children with (2011) (0)
- 5 Gene therapy of viral infections: The use of retroviral vectors expressing catalytic and antisense RNAs (1993) (0)
- A comparison of cost-effectiveness of peginterferon alfa-2a plus ribavirin vs interferon alfa-2b plus ribavirin as first treatment of chronic hepatitus C (2003) (0)
- Long-term liver function changes and related risk factors after direct-acting antiviral therapy in HCV-infected cirrhotic patients: results from a prospective web-based regional platform (2019) (0)
- Effectiveness and safety of DAA treatment for recurrent hepatitis C after liver transplantation: The NAVIGATOR Lombardia-Veneto network (2018) (0)
- SAT-262-Long-term liver function outcome and related risk factors in HCV cirrhotic patients treated with direct-acting antiviral therapy: Results from the Navigatore platform in Veneto-Italy (2019) (0)
- T and K cell function in acute and chronic hepatitis (1976) (0)
- PC.01.9 ESOPHAGEAL MICROBIOTA COMPOSITION ACROSS BARRETT'S ESOPHAGUS-DYSPLASIA-EAC SEQUENCE (2019) (0)
- Recombinant DNA techniques in the study of hepatitis B virus infection (1985) (0)
- Diagnostic algorithms for liver fibrosis in hepatitis C: Are they ready to avoid liver biopsy? (2012) (0)
- 562 Long-term follow-up of chronic hepatitis C patients — response to therapy and incidence of liver-related complications (2003) (0)
- OC.07.7 INSULIN-MEDIATED ESOPHAGEAL ADENOCARCINOMA DEVELOPMENT RELATED TO CHRONIC DUODENUM-ESOPHAGEAL REFLUX IN A HYPERINSULINEMIC AND NON-OBESE MURINE MODEL (2016) (0)
- Abstract of the XIV congress of the Italian society of electron microscopyElectron microscope detection of viruslike particles in blood products implicated for non-A, non-B hepatitis (1983) (0)
- Analysis of immunoglobulin variable kappa gene mutations in cutaneous B-cell lymphoma. (2007) (0)
- [Clinical aspects and risk factors in posttransfusion hepatitis]. (1984) (0)
- P.10.28 INSULIN RESISTANCE IN BARRETT'S ESOPHAGUS DEVELOPMENT AND EVOLUTION TO CANCER (2014) (0)
- Changes in liver membrane antigenicity and intracellular viral antigens expression in hepatitis B virus-infected hepatocytes (1982) (0)
- Serum levels of soluble CD30 in chronic hepatitis type B (1995) (0)
- Alpha-2 Recombinant Interferon Therapy for Chronic Hepatits Type B (1988) (0)
- CLINICAL RELEVANCE OF SERUM HBV-DNA TESTING IN PATIENTS WITH HBeAg POSITIVE INFECTION (1985) (0)
- Contents, Vol. 39, 1988 (1988) (0)
- Liver microsomal trygliceride transfer protein (MTP) is involved in HCV related hepatic steatosis through genotype specific pathways (2005) (0)
- Hepatitis C virus infection in hemodialyzed patients detected by I and II generation assays (1991) (0)
- OC-19 Donor/recipient seven gene signature (cirrhosis risk score) and donor age as predictors of liver fibrosis progression due to hepatitis C recurrence after liver transplantation (2013) (0)
- SEQUENCE ANALYSIS OF TWO PKR INHIBITOR HCV PROTEINS: CORRELATION WITH EARLY AND SUSTAINED RESPONSE TO INTERFERON THERAPY (2000) (0)
- Therapy of chronic viral hepatitis. (1991) (0)
- Liver steatosis reduces the virological response to antiviral therapy in HCV-1/2 but not in HCV-3 infected patients (2003) (0)
- A Controlled Trial of Alpha-2 Recombinant Interferon in Chronic Hepatitis Type B: A Preliminary Report (1988) (0)
- Cell mediated immunity to the hepatitis B virion in chronic hepatitis B virus infection. (1985) (0)
- NATIVE HEPATITIS B VIRUS PARTICLES INTERACT WITH THE HBV-BINDING PROTEIN IN TRANSFECTED CELLS (2000) (0)
- Management of HCV-2 and HCV-3 non-responders and relapsers. (2010) (0)
- Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks (2019) (0)
- OC.10.5: THE EFFECT OF PREVALENCE OF LIVER FIBROSIS STAGES IN PERFORMANCE OF NONINVASIVE FIBROSIS BIOMARKERS IN CHRONIC LIVER DISEASES (CLDS): RESULTS OF AN INDEPENDENT, INTERNATIONAL STUDY (2011) (0)
- HCV GENOTYPE, TISSUE HCV ANTIGENS; EXPRESION OF HLA-A,B,C AND ICAM-1 MOLECULES: RELEVANCE TO PATHOGENESIS OF HEPATOCELLULAR DAMAGE AND RESPONSE TO INTERFERON TREATMENT (1994) (0)
- INTRAFAMILIAL SPREADING OF HCV INFECTION: ANALYSIS OF HCV GENOTYPES (1995) (0)
- Heteroimmune and Autoimmune Reactions to Liver Cell Surface Antigens in the Pathogenesis of Acute and Chronic Hepatitis1 (1976) (0)
- Different modulation of PKR gene expression by HCV genotypes (2002) (0)
- Killing of antigen-splcific B cells by MHC-restricted pre-S2 specific cytotoxic T cell clones (1989) (0)
- I-41 Pathogenesis and clinical impact of insulin resistance in chronic HCV infection (2008) (0)
- Direct comparison of 5 different treatment strategies for hepatocellular carcinoma (HCC) in cirrhosis: Survival according to disease stage. (2005) (0)
- [Study of the hepatitis B virus-neutralizing response in acute infection and in patients vaccinated against the infection]. (1986) (0)
- Different patterns of hepatocellular carcinoma development in cirrhosis associated with hepatitis B virus and hepatitis C virus: a long-term prospective study (2001) (0)
- Development of hepatocellular carcinoma in cirrhosis of viral etiology: A prospective study (1991) (0)
- A CONTROLLED TRIAL OF ALPHA-2 INTERFERON FOR CHRONIC HBeAg- POSITIVE HEPATITIS (1988) (0)
- Hcv Genotypes in Italian Patients With Chronic Hcv Infection: A Prospective Multicentre Study (1996) (0)
- 647 INSULIN DIRECTLY INHIBITS IFN-α SIGNALING IN HEPATIC CELLS THROUGH A SOCS3 INDEPENDENT PATHWAY (2010) (0)
- From Bench to Bedside (2005) (0)
- The safe (sequential algorithm for fibrosis evaluation) biopsy: A new approach to stage fibrosis in chronic hepatitis C (2008) (0)
- Hbv-Dna Ed Epatocarcinoma in Eta` Pediatrica (1987) (0)
- Interferon treatment of anti-HBe positive and HBV-DNA positive chronic hepatitis type B. (1989) (0)
- Multivariate analysis of prognostic factors in chronic hepatitis type B (1989) (0)
- F-43 A multicenter prospective observational study to evaluate factors influencing efficacy, tolerance and compliance to antiviral tretament with interferon and ribavirin in daily clinical practice (2011) (0)
- The diagnostic performance of different non-invasive markers of liver fibrosis (LF) varies according to etiology of liver disease (2006) (0)
- The response to lymphoblastoid interferon of anti-HBe and HBV-DNA positive patients with chronic hepatitis B (1990) (0)
- IFN treatment in viral Hepatitis really affect mood and cognition? Neuropsychological Changes and Electrophysiological correlates (2002) (0)
- Treatment of hepatitis C with telaprevir (2013) (0)
- Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients (2016) (0)
- Non-invasive markers of liver fibrosis: How to use them in clinical practice? (2007) (0)
- AntiHBe and HBV-DNA positive chronic hepatitis B: clinical aspects and response to interferon therapy. (1987) (0)
- Lymphoblastoid interferon therapy for anti-HBe/HBV-DNA positive chronic hepatitis (1989) (0)
- High prevalence and incidence of cholecystolithiasis in liver cirrhosis (1992) (0)
- Hepatitis B virus and primary hepatic tumors in Italian children (1989) (0)
- Hepatitis associated antigen and anti-HAA immune complexes with excess of antigen or of antibody detected by radio-immunoprecipitation assay. (1974) (0)
- Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases (2008) (0)
- Reactivation of chronic hepatitis B virus infection (1985) (0)
- P.08.4: Prevention of Esophageal Adenocarcinoma in Barrett’s Esophagus Patients: A Moderate Calorie-Protein Restriction Program (CARE-PRO) (2017) (0)
- OC.06.4 INSULIN SIGNALING IN BARRETT'S ESOPHAGUS: IN VITRO AND IN PATIENTS STUDIES (2013) (0)
- A critical appraisal of current approaches to treatment of chronic hepatitis B (CHB)based on a review by an international panel of investigators and a survey of AASLD membership (2005) (0)
- Hepatitis C treatment with a focus on HCV protease inhibitors (Part Three) (2013) (0)
- Intrahepatic localization of hepatitis B virus (HBV) antigenic systems in acute and chronic hepatitis and in healthy carriers. (1977) (0)
- Infectious keratoconjunctivitis in calves: role of Mycoplasma bovis (2004) (0)
- Treatment of chronic hepatitis C in special patient populations (2010) (0)
- [Liver-specific proteins and autoimmunity in inflammatory liver diseases]. (1976) (0)
- Retrospective analysis of the effect of interferon therapy on clinical course of disease and on hepatocellular carcinoma (HCC) development in cirrhosis (1997) (0)
- Outcome and prognostic factors of untreated hepatocellular carcinoma (HCC) on cirrhosis: Survival analysis of 559 patients (2006) (0)
- DIFFERENT RATES OF HCV QUASISPECIES DIVERSIFICATION IN ASYMPTOMATIC CARRIERS AND IN PATIENTS WITH CHRONIC HEPATITIS (1999) (0)
- Combined lymphoblastoid alpha interferon and levamisole treatment of chronic hepatitis B virus infection (1992) (0)
- protein is found in some patients with mixed cryoglobulinemia type 2 A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope (2013) (0)
- Soluble interleukin-2 receptor in viral hepatitis and the effect of alpha-interferon therapy (1988) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alfredo Alberti?
Alfredo Alberti is affiliated with the following schools:
